Treace Medical Concepts, Inc. Advertising Expense
Treace Medical Concepts, Inc. (TMCI) reported Advertising Expense of $6.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-02-27
- Treace Medical Concepts, Inc. advertising expense for fiscal 2025 was $6.60M, a 55.41% decline from fiscal 2024.
- Treace Medical Concepts, Inc. advertising expense for fiscal 2024 was $14.80M, a 8.07% decline from fiscal 2023.
- Treace Medical Concepts, Inc. advertising expense for fiscal 2023 was $16.10M, a 7.33% increase from fiscal 2022.
- Treace Medical Concepts, Inc. advertising expense for fiscal 2022 was $15.00M, a 15.38% increase from fiscal 2021.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $6.60M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $14.80M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $16.10M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $15.00M 10-K · filed 2025-02-27 | |
| 2021-12-31 | $13.00M 10-K · filed 2024-02-27 | $13.02M 10-K · filed 2022-03-04 |
| 2020-12-31 | $3.10M 10-K · filed 2023-03-08 | |
| 2019-12-31 | $1.90M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |